ADHERE: randomized controlled trial comparing renal function in de novo kidney transplant recipients receiving prolonged-release tacrolimus plus mycophenolate mofetil or sirolimus

Oleg O. Rummo*, Mario Carmellini, Lionel Rostaing, Rainer Oberbauer, Maarten H. L. Christiaans, Christiane Mousson, Robert M. Langer, Franco Citterio, Bernard Charpentier, Malcolm Brown, Gbenga Kazeem, Frank Lehner, ADHERE Study Investigators

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)83-95
Number of pages13
JournalTransplant International
Volume30
Issue number1
DOIs
Publication statusPublished - Jan 2017

Keywords

  • calcineurin antagonists
  • immunosuppression
  • kidney clinical
  • outcome
  • GLOMERULAR-FILTRATION-RATE
  • ALLOGRAFT RECIPIENTS
  • MULTICENTER
  • INHIBITORS
  • REJECTION
  • OUTCOMES
  • IMMUNOSUPPRESSION
  • COMBINATION
  • WITHDRAWAL
  • EXPOSURE

Cite this